3543-73-5
Product Name:
1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester
Formula:
C14H19N3O2
Inquiry
SAFETY INFORMATION
Signal word | Warning |
---|---|
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation |
Precautionary Statement Codes |
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
COMPUTED DESCRIPTORS
Molecular Weight | 261.32 g/mol |
---|---|
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 261.147726857 g/mol |
Monoisotopic Mass | 261.147726857 g/mol |
Topological Polar Surface Area | 70.1 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 311 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
One of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of GUILLAIN-BARRE SYNDROME associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p385)
RELATED SUPPLIERS
Aspen Biopharma Labs Pvt Ltd
1Y
product:3543-73-5 Ethyl 4-(5-amino-1-methyl-1H-benzoimidazol-2-yl)-butyrate 98%